FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070864410> ?p ?o ?g. }

• W2070864410 endingPage "76" @default.
• W2070864410 startingPage "66" @default.
• W2070864410 abstract "Although many anticancer agents have been evaluated as radiosensitizing agents in cancer patients, none has demonstrated unequivocal clinical efficacy. Paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ) has been shown to enhance tumor cell response to ionizing radiation in cell culture studies. The pharmacokinetics and pharmacodynamics of paclitaxel in cancer patients receiving other highly metabolized drugs have not been well described and will be a key consideration in the development of the drug as a radiosensitizing agent. In addition, drug interaction studies demonstrate that administration sequence of paclitaxel with other chemotherapeutic agents, including cisplatin, doxorubicin, and cyclophosphamide, likely will affect its radiosensitizing efficacy. Other drugs that may affect paclitaxel radiosensitizing efficacy include corticosteroids and anticonvulsants; these interactions are particularly important in patients with central nervous system tumors, as is the question of whether paclitaxel can penetrate the blood-brain barrier. Overall, paclitaxel pharmacokinetics appear to favor radiosensitization, and results from an ongoing series of randomized trials should help define the drug's role in this setting. In contrast, amifostine, a sulfhydryl-containing agent, is currently being evaluated as a radioprotectant for normal tissues in patients who are receiving radiation therapy. Recent clinical trials have focused on amifostine's ability to reduce platinum-induced nephrotoxicity, although the drug was originally developed as a radioprotectant. Phase I clinical trials suggest that amifostine may be administered in much lower doses for radioprotectaon than those required for protection from platinuminduced nephrotoxicity. Amifostine pharmacokinetics support this finding; elimination of the drug may be dose dependent with clearance saturated at high doses, leading to increased risk of toxicity with no added radioprotectant benefit. Large randomized trials evaluating both paclitaxel as a radiosensitizer and amifostine as a radioprotectant are needed to make any firm conclusions regarding efficacy of either drug in modulating cancer therapy." @default.
• W2070864410 created "2016-06-24" @default.
• W2070864410 creator A5070130751 @default.
• W2070864410 date "1997-07-01" @default.
• W2070864410 modified "2023-09-26" @default.
• W2070864410 title "Clinical pharmacology of taxanes as radiosensitizers and the thiol-based radioprotectant amifostine" @default.
• W2070864410 cites W136550933 @default.
• W2070864410 cites W1481358348 @default.
• W2070864410 cites W1542404140 @default.
• W2070864410 cites W1630180746 @default.
• W2070864410 cites W1723772693 @default.
• W2070864410 cites W174629306 @default.
• W2070864410 cites W1799770165 @default.
• W2070864410 cites W1816481860 @default.
• W2070864410 cites W1836451026 @default.
• W2070864410 cites W1837236202 @default.
• W2070864410 cites W1847959577 @default.
• W2070864410 cites W1862654781 @default.
• W2070864410 cites W1880338082 @default.
• W2070864410 cites W1938913229 @default.
• W2070864410 cites W1943262843 @default.
• W2070864410 cites W1960713055 @default.
• W2070864410 cites W1963684703 @default.
• W2070864410 cites W1975420529 @default.
• W2070864410 cites W1980897034 @default.
• W2070864410 cites W1981019686 @default.
• W2070864410 cites W1983697092 @default.
• W2070864410 cites W1984446074 @default.
• W2070864410 cites W19927854 @default.
• W2070864410 cites W2008318438 @default.
• W2070864410 cites W2022743889 @default.
• W2070864410 cites W2025800550 @default.
• W2070864410 cites W2026349090 @default.
• W2070864410 cites W2029000080 @default.
• W2070864410 cites W2029128019 @default.
• W2070864410 cites W2042809007 @default.
• W2070864410 cites W2043356086 @default.
• W2070864410 cites W2043750157 @default.
• W2070864410 cites W2046653234 @default.
• W2070864410 cites W2066522045 @default.
• W2070864410 cites W2067299834 @default.
• W2070864410 cites W2078877172 @default.
• W2070864410 cites W2080339020 @default.
• W2070864410 cites W2084536512 @default.
• W2070864410 cites W2089519659 @default.
• W2070864410 cites W2089831557 @default.
• W2070864410 cites W2096102243 @default.
• W2070864410 cites W2102903528 @default.
• W2070864410 cites W2106257072 @default.
• W2070864410 cites W2106711796 @default.
• W2070864410 cites W2114068859 @default.
• W2070864410 cites W2128978033 @default.
• W2070864410 cites W2137597770 @default.
• W2070864410 cites W2138070201 @default.
• W2070864410 cites W2143202928 @default.
• W2070864410 cites W2145874366 @default.
• W2070864410 cites W2151724311 @default.
• W2070864410 cites W2153449460 @default.
• W2070864410 cites W2162970254 @default.
• W2070864410 cites W2165982968 @default.
• W2070864410 cites W2168284025 @default.
• W2070864410 cites W2179539336 @default.
• W2070864410 cites W2203588727 @default.
• W2070864410 cites W2222845202 @default.
• W2070864410 cites W2232368099 @default.
• W2070864410 cites W2240623839 @default.
• W2070864410 cites W2412518253 @default.
• W2070864410 cites W2418814713 @default.
• W2070864410 cites W2464403712 @default.
• W2070864410 cites W2993056846 @default.
• W2070864410 cites W575444618 @default.
• W2070864410 cites W302170882 @default.
• W2070864410 doi "https://doi.org/10.1016/s1053-4296(97)80061-6" @default.
• W2070864410 hasPublicationYear "1997" @default.
• W2070864410 type Work @default.
• W2070864410 sameAs 2070864410 @default.
• W2070864410 citedByCount "0" @default.
• W2070864410 crossrefType "journal-article" @default.
• W2070864410 hasAuthorship W2070864410A5070130751 @default.
• W2070864410 hasConcept C111113717 @default.
• W2070864410 hasConcept C112705442 @default.
• W2070864410 hasConcept C126322002 @default.
• W2070864410 hasConcept C143998085 @default.
• W2070864410 hasConcept C2776694085 @default.
• W2070864410 hasConcept C2777292972 @default.
• W2070864410 hasConcept C2778239845 @default.
• W2070864410 hasConcept C2779387952 @default.
• W2070864410 hasConcept C2780035454 @default.
• W2070864410 hasConcept C2781451048 @default.
• W2070864410 hasConcept C535046627 @default.
• W2070864410 hasConcept C71924100 @default.
• W2070864410 hasConcept C98274493 @default.
• W2070864410 hasConceptScore W2070864410C111113717 @default.
• W2070864410 hasConceptScore W2070864410C112705442 @default.
• W2070864410 hasConceptScore W2070864410C126322002 @default.
• W2070864410 hasConceptScore W2070864410C143998085 @default.
• W2070864410 hasConceptScore W2070864410C2776694085 @default.
• W2070864410 hasConceptScore W2070864410C2777292972 @default.

• next